35 related articles for article (PubMed ID: 16482499)
1. Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype.
Blanca A; Lopez-Beltran A; Lopez-Porcheron K; Gomez-Gomez E; Cimadamore A; Bilé-Silva A; Gogna R; Montironi R; Cheng L
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046810
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of cyclin D3 expression in malignancy patients: a meta-analysis.
Wang B; Wang Z; Han L; Gong S; Wang Y; He Z; Feng Y; Yang Z
Cancer Cell Int; 2019; 19():158. PubMed ID: 31198407
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of cyclin D2/D3 in multiple human malignant neoplasms: A systematic review and meta-analysis.
Ding ZY; Li R; Zhang QJ; Wang Y; Jiang Y; Meng QY; Xi QL; Wu GH
Cancer Med; 2019 Jun; 8(6):2717-2729. PubMed ID: 30950241
[TBL] [Abstract][Full Text] [Related]
4. Roles of Signal Transducer Pathways in Investigation of Biopsies from Patients with Bladder Tumors.
Bayrak A; Palanduz S; Coskunpinar E; Sanli O; Armagan A; Karakus S; Topaktas R; Cefle K; Ozturk S; Ucur A
Asian Pac J Cancer Prev; 2017 Jan; 18(1):201-205. PubMed ID: 28240520
[TBL] [Abstract][Full Text] [Related]
5. Urinary Bladder Cancer: Biomarkers and Target Therapy, New Era for More Attention.
Mohammed AA; El-Tanni H; El-Khatib HM; Mirza AA; Mirza AA; Alturaifi TH
Oncol Rev; 2016 Oct; 10(2):320. PubMed ID: 28058098
[TBL] [Abstract][Full Text] [Related]
6. Understanding the molecular pathogenesis and prognostics of bladder cancer: an overview.
Zhao M; He XL; Teng XD
Chin J Cancer Res; 2016 Feb; 28(1):92-8. PubMed ID: 27041931
[TBL] [Abstract][Full Text] [Related]
7. Emerging critical role of molecular testing in diagnostic genitourinary pathology.
Netto GJ; Cheng L
Arch Pathol Lab Med; 2012 Apr; 136(4):372-90. PubMed ID: 22458900
[TBL] [Abstract][Full Text] [Related]
8. Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
Netto GJ
Nat Rev Urol; 2011 Dec; 9(1):41-51. PubMed ID: 22158597
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D3 gene amplification in bladder carcinoma in situ.
Lopez-Beltran A; Ordóñez JL; Otero AP; Blanca A; Sevillano V; Sanchez-Carbayo M; Muñoz E; Cheng L; Montironi R; de Alava E
Virchows Arch; 2010 Nov; 457(5):555-61. PubMed ID: 20821231
[TBL] [Abstract][Full Text] [Related]
10. D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance.
Levidou G; Saetta AA; Karlou M; Thymara I; Pratsinis H; Pavlopoulos P; Isaiadis D; Diamantopoulou K; Patsouris E; Korkolopoulou P
J Cancer Res Clin Oncol; 2010 Oct; 136(10):1563-71. PubMed ID: 20174823
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
12. Molecular alterations in bladder cancer.
Cordon-Cardo C
Cancer Surv; 1998; 32():115-31. PubMed ID: 10489625
[TBL] [Abstract][Full Text] [Related]
13. Molecular biological changes in bladder cancer.
Qureshi KN; Lunec J; Neal DE
Cancer Surv; 1998; 31():77-97. PubMed ID: 15281318
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D3 expression in primary Ta/T1 bladder cancer.
Lopez-Beltran A; Requena MJ; Luque RJ; Alvarez-Kindelan J; Quintero A; Blanca AM; Rodriguez ME; Siendones E; Montironi R
J Pathol; 2006 May; 209(1):106-13. PubMed ID: 16482499
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R
Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R
Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
